Explore more publications!

Press Releases

Spark Spine Secures Core Intellectual Property with Notice of Allowance for EMP Technology
Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit
Edible Garden’s Gourmet Greens Hydroponic Basil Now Available at Hannaford
Regeneron Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Bodkin Design & Engineering Secures $200,000 DoD Contract to Develop On-Demand Laser Written Prescription Lenses
Workable Launches 'Next at Work,' a Podcast on the Future of Work, AI, and Leadership
Global Protein Expression Market Poised for 10.9% CAGR Expansion by 2030
Nuwellis Appoints Carisa Schultz as Chief Financial Officer
HYCU® Named a Leader in IDC MarketScape: Worldwide SaaS Data Protection 2025-2026 Vendor Assessment
BCC Research Highlights 5 Markets with 20%+ CAGR
AgileBrain Partners with Klitschko Foundation & Kyiv Digital to Support Emotional Wellbeing of 100,000 Kyiv Students
CarGurus Marks 20 Years of Automotive Leadership with Next Chapter of AI-Powered Innovation
BCC Research Releases Global Report on AI Disruption Across Industries and Regions
Black Mesa awarded ARPA-H funding to develop a ‘Good AI Practice’ (GAIP) framework
Vaxcyte Announces Pricing of $550 Million Public Offering
Visitor Spending Increased in December 2025 as Visitor Arrivals Declined

Visitor Spending Increased in December 2025 as Visitor Arrivals Declined

Anguilla Voted 2nd Best Island in the Caribbean by USA Today Readers
UPDATE - BPGbio Receives FDA Orphan Drug Designation for BPM31510 for the Treatment of Primary CoQ10 Deficiency
Clairity Appoints Founder Dr. Connie Lehman as Chief Executive Officer; Joe Kiani Named Chairman of the Board
Long-time childhood cancer advocate Paco Arango joins Oncoheroes board, fuels vital clinical trial

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions